[go: up one dir, main page]

NO20014477L - Behandling av osteoartritis - Google Patents

Behandling av osteoartritis

Info

Publication number
NO20014477L
NO20014477L NO20014477A NO20014477A NO20014477L NO 20014477 L NO20014477 L NO 20014477L NO 20014477 A NO20014477 A NO 20014477A NO 20014477 A NO20014477 A NO 20014477A NO 20014477 L NO20014477 L NO 20014477L
Authority
NO
Norway
Prior art keywords
osteoarthritis
treatment
Prior art date
Application number
NO20014477A
Other languages
English (en)
Other versions
NO20014477D0 (no
Inventor
Carl M Mendel
Timothy B Seaton
Steve P Weinstein
Original Assignee
Knoll Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Gmbh filed Critical Knoll Gmbh
Publication of NO20014477D0 publication Critical patent/NO20014477D0/no
Publication of NO20014477L publication Critical patent/NO20014477L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20014477A 1999-03-19 2001-09-14 Behandling av osteoartritis NO20014477L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12530099P 1999-03-19 1999-03-19
PCT/US2000/007072 WO2000056306A1 (en) 1999-03-19 2000-03-17 Treatment of osteoarthritis

Publications (2)

Publication Number Publication Date
NO20014477D0 NO20014477D0 (no) 2001-09-14
NO20014477L true NO20014477L (no) 2001-11-01

Family

ID=22419072

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20014477A NO20014477L (no) 1999-03-19 2001-09-14 Behandling av osteoartritis

Country Status (20)

Country Link
EP (1) EP1169027A4 (no)
JP (2) JP2002539248A (no)
KR (1) KR20020038567A (no)
CN (1) CN1352552A (no)
AU (1) AU773490B2 (no)
BG (1) BG105999A (no)
BR (1) BR0009081A (no)
CA (1) CA2366660A1 (no)
CZ (1) CZ20013284A3 (no)
HK (1) HK1044702A1 (no)
HU (1) HUP0200494A2 (no)
IL (1) IL145238A0 (no)
MX (1) MXPA01009461A (no)
NO (1) NO20014477L (no)
NZ (1) NZ514016A (no)
PL (1) PL365463A1 (no)
SK (1) SK13342001A3 (no)
TR (1) TR200102699T2 (no)
WO (1) WO2000056306A1 (no)
ZA (1) ZA200107682B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6974838B2 (en) 1998-08-24 2005-12-13 Sepracor Inc. Methods of treating or preventing pain using sibutramine metabolites
US6476078B2 (en) 1999-08-11 2002-11-05 Sepracor, Inc. Methods of using sibutramine metabolites in combination with a phosphodiesterase inhibitor to treat sexual dysfunction
US6399826B1 (en) 1999-08-11 2002-06-04 Sepracor Inc. Salts of sibutramine metabolites, methods of making sibutramine metabolites and intermediates useful in the same, and methods of treating pain
WO2002083631A1 (en) 2001-04-13 2002-10-24 Sepracor Inc. Methods of preparing didesmethylsibutramine and other sibutramine derivatives

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA821577B (en) * 1981-04-06 1983-03-30 Boots Co Plc Therapeutic agents
ZA836848B (en) * 1982-09-30 1984-05-30 Boots Co Plc Therapeutic agents
GB8531071D0 (en) * 1985-12-17 1986-01-29 Boots Co Plc Therapeutic compound
JP2675573B2 (ja) * 1988-03-31 1997-11-12 科研製薬株式会社 脳機能改善剤
IE61928B1 (en) * 1988-11-29 1994-11-30 Boots Co Plc Treatment of obesity
JPH08500093A (ja) * 1992-06-23 1996-01-09 セプラコア インコーポレーテッド 光学的に純粋な（−）シブトラミンを用いるうつ病およびその他の障害を治療する方法ならびに組成物
JPH07508281A (ja) * 1992-06-23 1995-09-14 セプラコア　インコーポレーテッド 光学的に純粋な（＋）シブトラミンを用いるうつ病およびその他の障害を治療する方法ならびに組成物
JP3862295B2 (ja) * 1993-09-30 2006-12-27 独立行政法人理化学研究所 抗肥満剤
US5459164A (en) * 1994-02-03 1995-10-17 Boots Pharmaceuticals, Inc. Medical treatment
DE69514798D1 (de) * 1994-06-01 2000-03-02 Axys Pharm Inc Zusammensetzungen und verfahren zur behandlung von durch mast-zellen verursachten krankheiten
GB9619962D0 (en) * 1996-09-25 1996-11-13 Knoll Ag Medical treatment
MA24500A1 (fr) * 1997-03-21 1998-10-01 Lg Life Sciences Ltd Derive du sel d'acide carboxylique de naphthyridine .

Also Published As

Publication number Publication date
WO2000056306A1 (en) 2000-09-28
JP2012051904A (ja) 2012-03-15
SK13342001A3 (sk) 2002-04-04
CN1352552A (zh) 2002-06-05
AU773490B2 (en) 2004-05-27
PL365463A1 (en) 2005-01-10
IL145238A0 (en) 2002-06-30
HUP0200494A2 (en) 2002-08-28
MXPA01009461A (es) 2004-03-19
NO20014477D0 (no) 2001-09-14
AU3893200A (en) 2000-10-09
ZA200107682B (en) 2003-06-18
TR200102699T2 (tr) 2002-03-21
CA2366660A1 (en) 2000-09-28
EP1169027A1 (en) 2002-01-09
HK1044702A1 (zh) 2002-11-01
BG105999A (en) 2002-06-28
EP1169027A4 (en) 2004-10-20
KR20020038567A (ko) 2002-05-23
BR0009081A (pt) 2003-03-05
CZ20013284A3 (cs) 2002-10-16
JP2002539248A (ja) 2002-11-19
NZ514016A (en) 2001-09-28

Similar Documents

Publication Publication Date Title
NO20013380D0 (no) 2-aminobenzoksazinonderivater for behandling av fedme
NO20013381D0 (no) 2-oksybenzoksazinonderivater for behandling av fedme
NO20014379L (no) Anvendelse av Xenon for behandling av Neurointoksikasjoner
NO20013369D0 (no) Arylpiperazinyl-cykloheksyl-indol-derivater for behandling av depresjon
FI20000863A0 (fi) Uusi hoitomenetelmä
NO20022087D0 (no) Fremgangsmåte for behandling av diabetes
NO20024775D0 (no) Hydroksyfenyl-piperidin-4-yliden-metyl-benzamidderivater til behandling av smerte
NO20022245D0 (no) Onkolyttiske kombinasjoner for behandling av cancer
EP1117431A4 (en) TREATMENT OF ACIDOSIS
NO20024777D0 (no) Kinolinyl-piperidin-4-yliden-metyl-benzamidderivater til behandling av smerte
NO20024776D0 (no) Hydroksyfenyl-piperazinyl-metyl-benzamidderivater til behandling av smerte
NO20020784L (no) Medikament for behandling av brudd
NO20013596D0 (no) Slambehandling
ATE302165T1 (de) Wasserbehandlung
PT1178984E (pt) Derivados de 1-trifluorometil-4-hidroxi-7-piperidinilamimometilcromano
NO20014477D0 (no) Behandling av osteoartritis
NO20003529D0 (no) Behandling av dyskinesi
EP1225919A4 (en) TREATMENT OF CANCER
NO20014845D0 (no) Anvendelse av arylalkanoylpyridaziner
SE0300535L (sv) Behandling av brännskador
PT1232141E (pt) Eteres de o-desmetil-venlafaxina
NO20014476L (no) Behandling av hiatial hernia
NO20014093L (no) Behandling av infertilitet
NO20014092L (no) Behandling av infertilitet
EE200200053A (et) Isoretinoiini valmistamise protsess